50 results on '"Katz, Stephen M."'
Search Results
2. Poster Board #-Session: P112-I Successful Transplantation of Donor Specific Antibody Positive, Crossmatch Negative (AHG/FCXM) Renal Allograft Recipients.: Abstract# 769
3. Comparing a corticosteroid and calcineurin-free immunosuppression protocol to a conventional sirolimus, cyclosporine and prednisone-based regimen for pancreas-kidney transplantation: 105.3
4. Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients
5. Long-term outcomes of single paediatric vs. ideal adult renal allograft transplants in adult recipients
6. SUCCESSFUL THERAPY OF ANTIBODY MEDIATED REJECTION: OR-094
7. PEDIATRIC DONOR KIDNEYS - HOW THEY WORK? COMPARISON OF OUTCOME FOR “IDEAL” ADULT KIDNEY TRANSPLANT TO SINGLE PEDIATRIC ONES: OR-069
8. Gene order in the major histocompatibility complex of the rat
9. 94-P C1q positive antibodies in patients with donor specific HLA antibodies and post transplant rejection
10. 63-P The relevance of pre-transplant soluble HLA-G levels and/or donor specific HLA antibodies on renal allograft survival
11. 26-P: Frequency of Donor Specific HLA (DSA) Antibody in a Transplant Population and Their Clinical Impact
12. Comparing an Early Corticosteroid/Late Calcineurin-Free Immunosuppression Protocol to a Sirolimus-, Cyclosporine A-, and Prednisone-Based Regimen for Pancreas-Kidney Transplantation
13. 55-OR: Antibody amount, does not predict crossmatch
14. 49-OR: Consequences of allocating deceased donor organs based on recipient antibody specificities
15. Immature Syngeneic Dendritic Cells Potentiate Tolerance to Pancreatic Islet Allografts Depleted of Donor Dendritic Cells in Microgravity Culture Condition
16. 42-OR
17. A Multicenter, Prospective Study of C2-Monitored Cyclosporine Microemulsion in a U.S. Population of De Novo Renal Transplant Recipients
18. Low Incidence of Malignancy among Sirolimus/Cyclosporine-Treated Renal Transplant Recipients
19. Spectral Theory of Linear Operators And Spectral Systems in Banach Algebras
20. A new assay to measure cell mediated responsiveness of renal allograft recipients: correlation to HLA AB
21. Choice of induction therapy for sirolimus treated renal recipients based upon immune risk factors
22. HLA antibody and donor reactivity define patients at risk for rejection or graft loss
23. Relevance of HLA matching and HLA antibodies to rejection and graft loss in liver recipients
24. Donor HLA, transplant, and graft loss result in similar recipient sensitization not affecting retranplant survival
25. Microgravity culture condition reduces immunogenicity and improves function of pancreatic islets1
26. De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination1
27. ICAM-1 Antisense Oligodeoxynucleotide Improves Islet Allograft Survival and Function
28. Low Intraindividual Variability of Cyclosporin A Exposure Reduces Chronic Rejection Incidence and Health Care Costs
29. ADDITION OF RAPAMYCIN TO CYCLOSPORINE-PREDNISONE BASED IMMUNOSUPPRESSION REDUCES THE CLINICAL RISK OF PRETRANSPLANT ANTI-HLA ANTIBODY ALLOSENSITIZATION.
30. MICROGRAVITY CULTURE CONDITIONS DECREASE IMMUNOGENICITY BUT MAINTAIN EXCELLENT MORPHOLOGY OF PANCREATIC ISLETS.
31. SERIAL POSTOPERATIVE IMMUNE MONITORING OF HUMORAL ALLOSENSITIZATION IDENTIFIES IMMUNOLOGICALLY HIGH RISK RECIPIENTS.
32. IMMUNOSUPPRESSIVE EFFECTS AND SAFETY OF A SIROLIMUS/CYCLOSPORINE COMBINATION REGIMEN FOR RENAL TRANSPLANTATION1
33. DECREASED PROTEIN BINDING OF MYCOPHENOLIC ACID ASSOCIATED WITH LEUKOPENIA IN A PANCREAS TRANSPLANT RECIPIENT WITH RENAL FAILURE
34. VARIABLE ORAL ABSORPTION OF CYCLOSPORINE
35. CORRELATION OF ELISA-DETECTED IgG AND IgA ANTI-HLA ANTIBODIES IN PRETRANSPLANT SERA WITH RENAL ALLOGRAFT REJECTION1
36. THE IMPACT OF ELEVATED SERUM IgA AND RACE ON PRIMARY RECIPIENT RENAL ALLOGRAFT SURVIVAL 1
37. Special Considerations in the Transplant Patient Requiring Other Surgery
38. Surgical Complications Of Liver Transplantation
39. Liver Transplantation: The Last Ten Years
40. POSITIVE PRETRANSPLANT CROSSMATCHES PREDICT EARLY GRAFT LOSS IN LIVER ALLOGRAFT RECIPIENTS
41. Influence Of Hla Matching On Rejections And Short - And Long-Term Primary Cadaveric Allograft Survival
42. Retransplantation following AHG-negative crossmatches.
43. Microgravity culture condition reduces immunogenicity and improves function of pancreatic islets1.
44. De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination1.
45. THE RELATIVE ROLES OF MHC AND NON-MHC GENES IN HEART AND SKIN ALLOGRAFT SURVIVAL.
46. Influence Of Hla Matching On Rejections And Short - And LongTerm Primary Cadaveric Allograft Survival
47. THE RELATIVE ROLES OF MHC AND NONMHC GENES IN HEART AND SKIN ALLOGRAFT SURVIVAL
48. 42-OR: Clinical relevance of crossmatch results, HLA and non-HLA antibodies for renal allograft recipients
49. ADDITION OF RAPAMYCIN TO CYCLOSPORINEPREDNISONE BASED IMMUNOSUPPRESSION REDUCES THE CLINICAL RISK OF PRETRANSPLANT ANTIHLA ANTIBODY ALLOSENSITIZATION.
50. A Father's War, A Son's Toxic Inheritance.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.